Novartis is a Swiss multinational pharmaceutical company headquartered in Basel, Switzerland. Formed in 1996 through the merger of Ciba-Geigy and Sandoz, the company's medicines reach 296 million people worldwide.
Arnd WiegmannFile Photo/Reuters
Novartis
Novartis in Fortune Rankings
- About
- Company Information
- World's Most Admired Companies
- Europe's Most Innovative Companies
- Key Financials (last Fiscal Year)
- Profit Ratios
- Updated:16/09/2026
- Country/Territory:Switzerland
- Headquarters:Basel
- Industry:Pharmaceuticals
- CEO:Vasant Narasimhan
- Website:https://www.novartis.com
- Ticker:NVS
- Company type:Public
- Revenues ($M):$56,674
- Profits ($M):$13,984
- Market value ($M):$289,792
- Number of employees:75,267
Figures prepared in accordance with International Accounting Standards. Market Value as of Aug. 31, 2026. Sources: Regulatory filings; S&P Global.
- Sector:Natural resources
- Industry:Pharmaceuticals
- Current All-Star Rank:-
- Previous All-Star Rank:-
- Industry Rank:6
- Previous Industry Rank:9
- Overall Score:7.35
- Innovation:5
- People Management:7
- Use of Corporate Assets:8
- Social Responsibility:7
- Quality of Management:6
- Financial Soundness:5
- Long-Term Investment Value:4
- Quality of Products/Services:7
- Global Competitiveness:3
- Sector:Health Care
- Country:Switzerland
- Strongest dimension:Product innovation
- Years on list:2
- Previous rank:28
- $ Millions% change
- Revenues ($M):$56,6749.57%
- Profits ($M):$13,98417.11%
- Assets ($M):$110,949-
- Total Stockholder Equity ($M):$46,130-
- Profit as % of Revenues:24.7%
- Profits as % of Assets:12.6%
- Profits as % of Stockholder Equity:30.3%
Novartis stock chart
Latest news on Novartis
Novartis in Fortune Rankings
- Fortune Global 500
- Europe's Most Innovative Companies
- World's Most Admired Companies
- Fortune 500 Europe
- World’s 25 Best Workplaces
- Change the World